NCT07712471

Brief Summary

This multicenter observational study evaluates the safety and effectiveness of ultrasound-guided thermal radiofrequency applied to the musculocutaneous nerve in adult patients with focal elbow flexor spasticity secondary to central nervous system injury. Hypothesis: Thermal radiofrequency treatment of the musculocutaneous nerve in patients with spasticity resulting from damage to the central nervous system is a safe and effective treatment for spasticity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 14, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 17, 2026

Completed
Last Updated

July 20, 2026

Status Verified

May 1, 2026

Enrollment Period

1.2 years

First QC Date

July 14, 2026

Last Update Submit

July 17, 2026

Conditions

Keywords

radiofrequencyThermal Radiofrequency Neurolysismuscle spasticityMusculocutaneous nerve

Outcome Measures

Primary Outcomes (2)

  • Goniometry

    Passive elbow range of motion assessed by goniometry. Maximum passive elbow extension is measured in degrees using a standard goniometer. Values range from -160°, indicating complete elbow flexion, to 0°, indicating complete elbow extension. Higher values (closer to 0°) indicate greater passive elbow extension and a better outcome, whereas more negative values indicate a worse outcome.

    Baseline, 2 months, and 6 months after treatment

  • Modified Ashworth Scale

    Elbow flexor muscle tone is assessed using the Modified Ashworth Scale, a 6-category ordinal scale with scores of 0, 1, 1+, 2, 3, and 4. The minimum score is 0, indicating no increase in muscle tone, and the maximum score is 4, indicating that the affected limb is rigid in flexion or extension. Higher scores indicate greater muscle tone and a worse outcome.

    Baseline, 2 months, and 6 months after treatment

Secondary Outcomes (5)

  • Goal Attaintment Scaling

    2 months, and 6 months after treatment.

  • Visual Analog Scale

    Baseline, 2 months, and 6 months after treatment

  • Spasticity-related Quality Of Life 6-Dimensions (SQoL-6D)

    Baseline, 2 months, and 6 months after treatment.

  • Physician Global Assessment (PGA)

    Baseline, 2 months, and 6 months after treatment.

  • Patient Global Impression of Change (PGI-C)

    Baseline, 2 months, and 6 months after treatment

Study Arms (1)

Thermal Radiofrequency of the Musculocutaneous Nerve for the Treatment of Spasticity

EXPERIMENTAL
Device: Radiofrequency

Interventions

Thermal Radiofrequency of the Musculocutaneous Nerve for the Treatment of Spasticity

Thermal Radiofrequency of the Musculocutaneous Nerve for the Treatment of Spasticity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent.
  • Age 18 years or older.
  • Diagnosis of spasticity secondary to central nervous system injury.
  • Predominant elbow flexor spastic pattern dependent on the musculocutaneous nerve.
  • Patients with severe spasticity refractory to conservative treatments who underwent thermal radiofrequency treatment of the musculocutaneous nerve during the study period.

You may not qualify if:

  • No signed informed consent.
  • Age under 18 years.
  • Radiofrequency treatment applied to patients without central nervous system injury.
  • Absence of follow-up after radiofrequency treatment, for any reason, for a minimum period of 2 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Complexo Hospitalario Universitario A Coruña

A Coruña, A Coruña, 15006, Spain

Location

MeSH Terms

Conditions

Muscle Spasticity

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor in Physical and Rehabilitation Medicine

Study Record Dates

First Submitted

July 14, 2026

First Posted

July 17, 2026

Study Start

February 1, 2025

Primary Completion

April 30, 2026

Study Completion

April 30, 2026

Last Updated

July 20, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to privacy and confidentiality considerations.

Locations